Literature DB >> 1964597

Molecular analysis of the ets genes and their products.

D K Watson1, R Ascione, T S Papas.   

Abstract

Organisms from human to Drosophila have been found to contain cellular sequences and transcripts that are homologous to the ets region of the avian retrovirus, E26. Ets-related sequences are present on at least two distinct functional loci in chickens and mammals, and have been designated ets-1 and ets-2. The E26 virus transduced sequences from the chicken ets-1 locus, which encompasses over 60 kb of DNA. The ets genes characterized so far from sea urchin and Drosophila are most closely related to the 3' end of the known ets genes. The predicted viral and avian ets proteins are very similar, except at the termini. The similarity between the predicted ets proteins so far described is discussed. The ets proteins have been identified and localized by immunoprecipitation and immunofluorescence. While the ets-1 proteins are found in the nuclear and cytoplasmic fractions, the viral gag-myb-ets protein (p135) and the ets-2 proteins are nuclear. The ets-1 and ets-2 genes are differentially regulated in different cell types, probably reflecting unique controlling elements. Because chromosomal translocations have been associated with different human leukemias, studies addressing the possible association with the ETS1 (11q23) or ETS2 (21q22.3) loci are reviewed.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 1964597

Source DB:  PubMed          Journal:  Crit Rev Oncog        ISSN: 0893-9675


  10 in total

1.  Both TEL and AML-1 contribute repression domains to the t(12;21) fusion protein.

Authors:  R Fenrick; J M Amann; B Lutterbach; L Wang; J J Westendorf; J R Downing; S W Hiebert
Journal:  Mol Cell Biol       Date:  1999-10       Impact factor: 4.272

Review 2.  Promiscuous partnerships in Ewing's sarcoma.

Authors:  Savita Sankar; Stephen L Lessnick
Journal:  Cancer Genet       Date:  2011-07

3.  Identification of a second promoter in the human c-ets-2 proto-oncogene.

Authors:  A Bègue; P Crepieux; N Vu-Dac; A Hautefeuille; N Spruyt; V Laudet; D Stehelin
Journal:  Gene Expr       Date:  1997

4.  Identification of a killer cell-specific regulatory element of the mouse perforin gene: an Ets-binding site-homologous motif that interacts with Ets-related proteins.

Authors:  H Koizumi; M F Horta; B S Youn; K C Fu; B S Kwon; J D Young; C C Liu
Journal:  Mol Cell Biol       Date:  1993-11       Impact factor: 4.272

5.  Epithelium-specific ets transcription factor 2 upregulates cytokeratin 18 expression in pulmonary epithelial cells through an interaction with cytokeratin 18 intron 1.

Authors:  Deanna Yaniw; Jim Hu
Journal:  Cell Res       Date:  2005-06       Impact factor: 25.617

6.  Transcriptional regulation of p21/CIP1 cell cycle inhibitor by PDEF controls cell proliferation and mammary tumor progression.

Authors:  Jeremy S Schaefer; Yamini Sabherwal; Heidi Y Shi; Venkataraman Sriraman; JoAnne Richards; Alex Minella; David P Turner; Dennis K Watson; Ming Zhang
Journal:  J Biol Chem       Date:  2010-02-05       Impact factor: 5.157

7.  Avian erythroblastosis virus E26: only one (myb) of two cell-derived coding regions is necessary for oncogenicity.

Authors:  Y Wu; P Duesberg
Journal:  Proc Natl Acad Sci U S A       Date:  1994-04-26       Impact factor: 11.205

Review 8.  Reflections on the pathogenesis of diseases caused by the acute avian leukosis/sarcoma viruses with special reference to avian erythroblastosis.

Authors:  C Darcel
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

9.  Potential contribution of SIM2 and ETS2 functional polymorphisms in Down syndrome associated malignancies.

Authors:  Arpita Chatterjee; Samikshan Dutta; Sanjit Mukherjee; Nupur Mukherjee; Avirup Dutta; Ashis Mukherjee; Swagata Sinha; Chinmay Kumar Panda; Keya Chaudhuri; Ananda L Roy; Kanchan Mukhopadhyay
Journal:  BMC Med Genet       Date:  2013-01-23       Impact factor: 2.103

10.  Overexpression of the Ets-1 transcription factor in human breast cancer.

Authors:  Y Buggy; T M Maguire; G McGreal; E McDermott; A D K Hill; N O'Higgins; M J Duffy
Journal:  Br J Cancer       Date:  2004-10-04       Impact factor: 7.640

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.